Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Coya Therapeutics (COYA) Shares Outstanding (2022 - 2025)

Coya Therapeutics (COYA) has disclosed Shares Outstanding for 4 consecutive years, with $20.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 25.3% to $20.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.9 million through Dec 2025, up 25.3% year-over-year, with the annual reading at $20.9 million for FY2025, 25.3% up from the prior year.
  • Shares Outstanding hit $20.9 million in Q4 2025 for Coya Therapeutics, up from $16.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $20.9 million in Q4 2025 to a low of $2.6 million in Q2 2022.
  • Historically, Shares Outstanding has averaged $12.3 million across 4 years, with a median of $14.5 million in 2023.
  • Biggest five-year swings in Shares Outstanding: skyrocketed 456.15% in 2023 and later rose 9.88% in 2025.
  • Year by year, Shares Outstanding stood at $2.6 million in 2022, then surged by 456.15% to $14.4 million in 2023, then rose by 15.98% to $16.7 million in 2024, then rose by 25.3% to $20.9 million in 2025.
  • Business Quant data shows Shares Outstanding for COYA at $20.9 million in Q4 2025, $16.7 million in Q3 2025, and $16.7 million in Q2 2025.